Keyphrases
Adrenal Suppression
40%
Airway Control
20%
Airway Hyperresponsiveness
80%
Amino
40%
Asthma Symptoms
40%
Asthmatic
100%
Bone Metabolism
20%
Bone Turnover
40%
Bone Turnover Markers
100%
Bronchial Challenge
40%
C-telopeptide
20%
Carboxyl Terminus
20%
Ciclesonide
100%
Creatinine Ratio
40%
Cross-linked
20%
Group-based
20%
High Dose
100%
Inhaled Corticosteroid Therapy
20%
Mannitol
40%
No Significant Difference
20%
Parallel Trials
20%
Persistent Asthma
20%
PIIINP
60%
Primary Care
20%
Propeptide
40%
Prospective Follow-up
100%
Prospective Randomized Trial
20%
Pulmonary Function
20%
Reliever Use
20%
Resorption
20%
Scotland
20%
Sensitive Biomarker
20%
Stored Samples
20%
Systemic Side Effects
40%
Tayside
20%
Telopeptide
20%
Type I Collagen
60%
Type III Collagen
20%
Urinary Cortisol
40%
Use Function
20%
Medicine and Dentistry
Adrenal Suppression
40%
Adverse Effect
20%
Adverse Event
20%
Airway Management
20%
Amino Terminal Sequence
40%
Asthma
60%
Biological Marker
20%
Bone Remodeling
20%
Bone Turnover
100%
Ciclesonide
100%
Collagen Type 1
60%
Collagen Type 3
20%
Corticosteroid Therapy
20%
Creatinine
40%
Drug Megadose
100%
Group Trial
20%
Hydrocortisone
40%
Low Drug Dose
100%
Lung Function
20%
Mannitol
40%
Ossification
20%
Post-Hoc Analysis
20%
Primary Health Care
20%
Respiratory Tract Allergy
80%
Salicylate Sodium
20%
Telopeptide
40%
Urinary System
40%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
20%
Asthma
60%
Biological Marker
20%
Ciclesonide
100%
Collagen Type 1
60%
Collagen Type 3
20%
Creatinine
40%
Group Trial
20%
Hydrocortisone
40%
Mannitol
40%
Respiratory Tract Allergy
80%
Salicylate Sodium
20%
Telopeptide
40%